Brachytherapy Devices Market SWOT Analysis, Top Players –Theragenics, Elekta, Boston Scientific Corporation, iCAD, Inc

Emergen Research Logo

Emergen Research Logo

The Brachytherapy Devices market size reached USD 957.60 Million in 2022 and is expected to register a revenue CAGR of 8.2% during the forecast period

VANCOUVER, BRITISH COLUMBIA, CANADA, June 4, 2024 /EINPresswire.com/ -- The global Brachytherapy Devices market, which reached USD 957.60 million in 2022, is projected to grow at a compound annual growth rate (CAGR) of 8.2% over the forecast period. This growth is fueled by several factors including the increasing prevalence of cancer, the aging population, and the high acceptance of minimally invasive surgeries.

Click To get SAMPLE PDF (Including Full TOC, Graphs & Charts, Table & Figures) https://www.emergenresearch.com/request-sample/2891

Key Drivers of Market Growth

Effectiveness of Brachytherapy: Brachytherapy, a form of internal radiation therapy, delivers radiation directly to the tumor, minimizing damage to surrounding healthy tissue. This method is particularly effective for treating prostate, breast, non-melanoma skin, and gynecological cancers. Its application extends to certain heart conditions as well.

Adoption of Minimally Invasive Surgeries: The preference for minimally invasive treatments is on the rise due to their benefits such as reduced pain, shorter hospital stays, less scarring, and higher accuracy. These advantages make brachytherapy a favorable option, driving market growth.

Rising Cancer Incidences: The growing number of cancer cases, particularly among the elderly, significantly boosts the demand for brachytherapy. According to the American Cancer Society, over 1.9 million new cancer cases and 609,820 cancer deaths were expected in the U.S. in 2023 alone.
Government Initiatives: Government support through cancer treatment programs further propels market growth. Initiatives like the White House Cancer Moonshot aim to reduce cancer death rates by 50% by 2047, while regional programs in countries like India are investing in advanced cancer treatment facilities.

Technological Advancements: Innovations in brachytherapy, such as image-guided brachytherapy (IBT), are enhancing treatment precision and outcomes. These technologies, including MRI, CT, and ultrasound-guided procedures, help in sparing healthy organs from radiation exposure.
Market Challenges

Despite the promising growth, the market faces challenges such as the high reimbursement rates for new radiation therapies like IMRT and proton therapy, which could potentially overshadow brachytherapy. Additionally, the risk of side effects and device recalls, such as the FDA recall of Elekta’s Oncentra Brachy in 2021, pose significant hurdles.

Market Segmentation

By Application: The prostate cancer segment leads the market due to its high incidence among older men. Cervical cancer is expected to witness the highest growth rate, driven by the increasing global prevalence and government initiatives for early detection and treatment.
By Product Type: Applicators and afterloaders dominate the market due to their widespread use in cancer treatment. Electronic brachytherapy is also growing steadily, particularly for treating advanced skin cancers.
By End Use: Hospitals account for the largest revenue share, benefiting from the availability of advanced technologies and skilled oncologists. The adoption of brachytherapy in hospitals is increasing, supported by governmental and private sector investments.
Browse Detailed Research report @ https://www.emergenresearch.com/industry-report/brachytherapy-devices-market

Notable Developments

Recent industry developments include the acquisition of Elekta’s brachytherapy solutions by iCAD, Inc., and the introduction of innovative devices such as BEBIG Medical’s robotic-guided HDR brachytherapy for prostate cancer. Additionally, initiatives like the launch of brachytherapy equipment at Tamil Nadu Government Multi Super Specialty Hospital in India highlight the expanding reach of brachytherapy treatments.

Some major players included in the global Brachytherapy Devices market report are:

Theragenics
Elekta
Boston Scientific Corporation
iCAD, Inc.
Varian Medical Systems, Inc.
Eckert & Ziegler
CIVCO Medical Solutions
BD (Becton, Dickinson and Company)
Perspective Therapeutics
Argon Medical Device
Merit Medical Systems
Siemens Healthcare Private Limited
IsoAid
Sun Nuclear Corporation
AngioDynamics
Hologic, Inc.
C4 Imaging
Concure Oncology

Brachytherapy Devices Latest Industry Updates

On 24 October 2023, International Cancer Expert Crops (ICEC) announced the collaboration with virtual platform Chartrounds, a global provider of radiation oncology as well as a site focused specifically on the practice of brachytherapy, to increase availability of cancer care expertise and develop a growing global network.

On 9 October 2023, CIVCO Radiotherapy and Qfix announced the introduction of a new brand, CQ Medical in order to reflects the company's vision and global leadership in high-quality, patient-centric radiotherapy solutions, as well as company declared the acquisition of CQ Medical with medical device companies Nanovi A/S and Advaray that manufacture hydrogel-based device to advance methods of image-guided pelvic brachytherapy.
Enquire for customization in Report @ https://www.emergenresearch.com/request-for-customization/2891

Brachytherapy Devices Market Segment Analysis

For the purpose of this report, Emergen Research has segmented global Brachytherapy Devices market on the basis of Dosage Type, Product Type, Technique Type, Application, End-Use, and region:

Dosage Type Outlook (Revenue, USD Million; 2019-2032)
High Dose Rate (HDR) Brachytherapy
Low Dose Rate (LDR) Brachytherapy
Pulse Dose Rate (PDR) Brachytherapy

Product Type Outlook (Revenue, USD Million; 2019-2032)
Seeds
Brachytherapy Applicators
Intracavitary Applicator
Interstitial Applicator
Others
Brachytherapy Afterloaders
Electronic Brachytherapy

Technique Type Outlook (Revenue, USD Million; 2019-2032)
Ultrasound-Guided Brachytherapy
Magnetic Resonance Imaging (MRI)-Guided Brachytherapy
Computed Tomography (CT)-Guided Brachytherapy
Power Doppler Imaging-Guided Brachytherapy
Poistron Emission Topography-Guided Brachytherapy

Application Outlook (Revenue, USD Million; 2019-2032)
Prostate Cancer
Breast Cancer
Cervical Cancer
Gynecological Cancers
Skin Cancer
Others

End-Use Outlook (Revenue, USD Million; 2019-2032)
Hospitals
Cancer Treatment Centers
Specialty Centers
Others

Regional Outlook (Revenue, USD Million; 2019-2032)
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Benelux
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Rest of APAC
Latin America
Brazil
Rest of LATAM
Middle East & Africa
Saudi Arabia
UAE
South Africa
Turkey
Rest of MEA
 
The Brachytherapy Devices market is set for robust growth, driven by technological advancements and increasing cancer incidences. With supportive government initiatives and a focus on minimally invasive treatments, the market is poised to make significant strides in the coming years, offering improved outcomes for cancer patients worldwide.

About Us:

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Eric Lee
Emergen Research
+91 90210 91709
sales@emergenresearch.com
Visit us on social media:
Facebook
Twitter
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.